Congenital Segmental Emphysema: An Evolving Lesion

King's College Hospital, Paediatric Surgery, London, United Kingdom.
European Journal of Pediatric Surgery (Impact Factor: 0.98). 03/2010; 20(2):78-81. DOI: 10.1055/s-0029-1246129
Source: PubMed

ABSTRACT Congenital segmental emphysema (CSE) is a newly-recognised sub-type of congenital parenchymal lung anomaly. It is characterised by antenatal detection and post-natal evolution from an initially solid segmental appearance to a hyperlucent and hyperinflated segment.
A retrospective review of a single-centre tertiary referral database between Jan 1994 and Dec 2007 was performed.
130 infants had antenatally detected lung anomalies, and of these 12 (9.2%) infants (initially labelled as congenital cystic adenomatoid malformation (CCAM)), showed features better defined as CSE. The lesions were described antenatally as non-progressive microcystic (n=6), hyperechogenic (n=2) or both (n=2). Early post-natal CT scans showed areas of solid segmental parenchyma, initial hyperlucency or microcysts. Subsequent CT imaging, however, showed evolution to segmental hyperlucency in areas previously solid and in 2 cases a central bronchocele was noted. Ten children underwent resectional surgery (segmentectomy n=4, lobectomy n=6) at a median age of 1 (range 0.4-5.2) year and the gross appearance of the resected specimen confirmed hyperinflated (not cystic) segments. Histological review showed localised abnormally dilated alveolar spaces in 7 cases. Adjacent areas consistent with type 2 CCAM were also seen (n=3).
CSE lies within the spectrum of both CCAM and sequestration but there is a definite post-natal evolution and volume change which presage symptoms. This may be associated with segmental bronchial atresia and progressive air trapping via collateral airways such as the interalveolar pores of Kohn.

Download full-text


Available from: Salvador J Diaz-Cano, Aug 15, 2015
  • Source
    • "Ces cas pourraient correspondre a ` une nouvelle entité dé crite appelé e emphysè me segmentaire congé nital [19]. Toutefois, contrairement a ` ce que dé crit Paramalingam et al. [19], les lé sions chez nos 5 sujets sont tout a ` fait stables. L'e ´ volution anté natale des malformations de notre sé rie a e ´ té comparable a ` celle dé crite dans la litté rature, stable dans plus de la moitié des cas ou involutives [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: For many diseases, the comparison of prenatal diagnosis with a histopathological reality is not always possible. Fetal lung pathology, with its high rate of surgery in postnatal, allows this assessment. This study proposes an approach to the reliability of prenatal diagnosis and analysis of the postnatal development of all children in care for congenital pulmonary malformation (CPM).
    Gynécologie Obstétrique & Fertilité 03/2015; 43(4). DOI:10.1016/j.gyobfe.2015.02.008 · 0.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intrapulmonary sequestrations are quite uncommon in pediatric age group. The preoperative diagnosis of pulmonary sequestration is not possible in most of the cases. A 2-year-old boy presented with recurrent episodes of chest infections and respiratory distress. A preoperative diagnosis of congenital lobar emphysema was made on the basis of chest radiograph and computed tomography scan. At operation, an intralobar pulmonary sequestration was found. The sequestration cyst was excised with uneventful recovery.
    Journal of Indian Association of Pediatric Surgeons 01/2011; 16(1):15-7. DOI:10.4103/0971-9261.74515
  • [Show abstract] [Hide abstract]
    ABSTRACT: The advent of universal antenatal ultrasonography in many countries has revealed the full spectrum of congenital thoracic malformations (CTMs) and presented clinicians with a number of practical dilemmas to do with diagnosis and management. We present a review of the most common forms of CTMs, including congenital cystic adenomatoid malformation, bronchopulmonary sequestration, and lobar and segmental emphysema.
    Seminars in Fetal and Neonatal Medicine 04/2012; 17(2):99-104. DOI:10.1016/j.siny.2012.01.011 · 3.13 Impact Factor
Show more